MLYS icon

Mineralys Therapeutics

164 hedge funds and large institutions have $889M invested in Mineralys Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 76 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
+15
Holders Change %
+10.07%
% of All Funds
2.2%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.12%
New
40
Increased
76
Reduced
30
Closed
24
Calls
$30K
Puts
$1.11M
Net Calls
-$1.08M
Net Calls Change
+$2.81M
Name Holding Trade Value Shares
Change
Shares
Change %
CP
1
Catalys Pacific
Japan
$120M
RCM
2
RA Capital Management
Massachusetts
$83.2M
SB
3
Samsara BioCapital
California
$76.8M
SOCM
4
SR One Capital Management
Pennsylvania
$42.3M
BlackRock
5
BlackRock
New York
$41.9M +$8.76M +647,733 +26%
Capital International Investors
6
Capital International Investors
California
$39.2M +$39.2M +2,899,020 New
IHAM
7
Integral Health Asset Management
New York
$36.5M +$5.41M +400,000 +17%
Vanguard Group
8
Vanguard Group
Pennsylvania
$31.5M +$3.94M +290,943 +14%
CP
9
Caligan Partners
New York
$27.3M -$1.79M -132,315 -6%
Franklin Resources
10
Franklin Resources
California
$24.4M +$319K +23,556 +1%
LCM
11
Laurion Capital Management
New York
$23.8M -$1.83M -135,602 -7%
SCM
12
Suvretta Capital Management
New York
$23.6M +$1.04M +76,733 +5%
State Street
13
State Street
Massachusetts
$19.5M +$12.5M +923,379 +178%
Pictet Asset Management
14
Pictet Asset Management
Switzerland
$17.2M +$725K +53,620 +4%
Jennison Associates
15
Jennison Associates
New York
$16.7M -$10.1M -743,711 -38%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$12.9M +$2.06M +152,560 +19%
AAA
17
Affinity Asset Advisors
New York
$12.2M -$2.71M -200,000 -18%
American Century Companies
18
American Century Companies
Missouri
$11.3M +$151K +11,165 +1%
CS
19
Candriam SCA
Luxembourg
$11.2M -$794K -58,646 -7%
BFM
20
Boothbay Fund Management
New York
$11.1M -$1.44M -106,477 -12%
O
21
OrbiMed
New York
$10.3M +$10.3M +760,351 New
SC
22
Stempoint Capital
New York
$8.55M +$8.55M +631,586 New
Goldman Sachs
23
Goldman Sachs
New York
$8.48M +$4.44M +328,392 +110%
Morgan Stanley
24
Morgan Stanley
New York
$7.95M -$432K -31,918 -5%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$7.77M +$1.3M +95,777 +20%